Advertisement
Screener

BIOATLA, INC. (BCAB) Increase (Decrease) in Accounts Payable, Related Parties

2.8 / 5 stars · 68/120 Roast Me

BIOATLA, INC. Increase (Decrease) in Accounts Payable, Related Parties

BIOATLA, INC. (BCAB) reported Increase (Decrease) in Accounts Payable, Related Parties of $300.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties · last filed 2026-08-13

  • BIOATLA, INC. increase (decrease) in accounts payable, related parties for the quarter ending 2025-09-30 was $0.00.
  • BIOATLA, INC. increase (decrease) in accounts payable, related parties for fiscal 2021 was $0.00.
  • BIOATLA, INC. increase (decrease) in accounts payable, related parties for fiscal 2020 was $0.00.
  • BIOATLA, INC. increase (decrease) in accounts payable, related parties for fiscal 2019 was -$88.00K.
Period endIncrease (Decrease) in Accounts Payable, Related Parties 3 monthIncrease (Decrease) in Accounts Payable, Related Parties 6 monthIncrease (Decrease) in Accounts Payable, Related Parties 9 monthIncrease (Decrease) in Accounts Payable, Related Parties 12 month
2026-06-30$300.00K
10-Q · filed 2026-08-13
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$0.00
10-Q · filed 2025-11-13
2025-06-30$0.00
10-Q · filed 2026-08-13
2024-09-30$1.77M
10-Q · filed 2025-11-13
2023-09-30$0.00
10-Q · filed 2024-11-07
2021-12-31$0.00
10-K · filed 2022-02-28
2020-12-31$0.00
10-K · filed 2022-02-28
2019-12-31-$88.00K
10-K · filed 2022-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
EXOZYMES INC. (EXOZ)United States$0.058B
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Tevogen Inc. (TVGN)United States$0.049B
Instil Bio, Inc. (TIL)United States$0.048B-1.73
LeonaBio, Inc. (LONA)United States$0.047B-0.61
BioStem Technologies, Inc. (BSEM)United States$0.069B
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02